| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Workplace Communication > Why Good Advice is Hurting Your Productivity and What To Do About It |
|
Just Other Articles - Why Good Advice is Hurting Your Productivity and What To Do About It
The next time the phrase “here’s what you should do” begins a path across your lips, you’d be wise to remember this quote from Gilbert K. Chesterto According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product n: “I owe my success to having listened respectfully to the very best advice, and then going away and doing the exact opposite.” Although u ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ually given with the best intentions, advice always reflects the needs, experiences, and now science tells us, the thought process, of the giver. M lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ore often than not, the needs of giver and receiver don’t match, creating frustration all around. Instead, some well-chosen questions, directed alo here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe g the lines of finding a solution, can inspire creative insights that the logical analysis of a problem can’t. Sound simplistic? Socratic-like que d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro tioning has long been used to help people think outside the box. Now, new research into brain functioning is validating the efficacy of guiding peo ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ple to find their own solutions. Scientists have discovered that every person’s brain processes information in a unique way, so the connections tha easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi yours makes to solve a problem will be completely different from those of another person wrestling with the same dilemma.(1) In addition, when the nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically mind is focused on reaching a desired outcome, the brain connects data in a brand new way, which creates “aha!” moments.(2) One practical way to a and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ pply these principles is to ask people open-ended questions (ones that can’t be answered with a “yes” or a “no”) instead of explaining how you woul ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi address an issue. Notice the difference between saying, “You should categorize your emails and respond to them only at 9:00am and 3:00pm,” and ask ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ng questions like, “Where do you need help prioritizing? What needs to change so that you can get projects done on time?” While the chance dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod of someone adopting the email schedule is slim, the open-ended queries focuses the person’s thinking on finding solutions that make sense to him or cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin her. Of course, there are times when suggestions are needed and appropriate, and open-ended questions can be useful in these cases as well. While tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen oaching an overwhelmed entrepreneur, for instance, I posed queries like, “What tasks can you delegate? How valuable would it be to make a list o t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel f priorities for the week?” It’s a sure bet that if I had said, “You should delegate more and write down your priorities,” the reply would have ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust been all of the reasons those ideas wouldn’t work! Whether you are running your own business or managing a business unit, department, or work team y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products try using open-ended questions to get your colleagues and staff members “thinking different.” If someone comes to you in a quandary, ask how you c . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de an help them think the matter through instead of jumping in with a fix. People are much more likely to follow through on their own ideas, and you m elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip y be amazed at the results you get from using this one simple technique. 1, 2: Quiet Leadership, © 2006 by David Rock, HarperCollins Publishers, N tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Sales Tip - Find the Pleasure or Find the Pain Strategic Planning One Answer to Beating Your Competition
|